Literature DB >> 27421741

Effects of hypoxia on osteogenic differentiation of mesenchymal stromal cells used as a cell therapy for avascular necrosis of the femoral head.

Gabriela Ciapetti1, Donatella Granchi2, Caterina Fotia2, Lucia Savarino2, Dante Dallari3, Nicola Del Piccolo3, Davide Maria Donati4, Nicola Baldini5.   

Abstract

BACKGROUND AIMS: Avascular necrosis of the femoral head (AVN) occurs as common result of various conditions or develops as a primary entity, with a high freqency in young adults. Because of its tendency toward osteoarthritis requiring total hip arthroplasty, alternative treatments are being advocated, including cell therapy with mesenchymal stromal cells (MSCs). Because osteonecrotic bone is a severely hypoxic tissue, with a 1-3% oxygen tension, the survival and function of multipotent cells is questionable.
METHODS: In this study, the proliferative, immunophenotypic and osteogenic properties of bone marrow (BM)-derived MSCs from a clinical series of patients with AVN were evaluated under in vitro conditions mimicking the hypoxic milieu of AVN to verify the rationale for cell therapy. MSCs retrieved from the iliac crest (BM-MSC) were isolated, expanded and induced to osteogenic differentiation under a 2% pO2 atmosphere (hypoxia) in comparison with the standard 21% pO2 (normoxia) that is routinely used in cell culture assays.
RESULTS: Both proliferation and colony-forming ability were significantly enhanced in hypoxia-exposed BM-MSCs compared with BM-MSCs under normoxia. The expression of bone-related genes, including alkaline phosphatase, Type I collagen, and osteocalcin was significantly increased under hypoxia. Moreover, mineral deposition after osteogenic induction was not hampered, but in some cases even enhanced under low oxygen tension.
CONCLUSIONS: These findings support autologous cell therapy as an effective treatment to stimulate bone healing in the hypoxic microenvironment of AVN.
Copyright © 2016 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  avascular necrosis; bone marrow stromal cells; bone regeneration; hypoxia

Mesh:

Substances:

Year:  2016        PMID: 27421741     DOI: 10.1016/j.jcyt.2016.06.005

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  11 in total

1.  Clinical and Radiographic Alterations in Bilateral Avascular Necrosis of the Femoral Head Following Laser Acupuncture: A Case Report.

Authors:  Ali Akbar Jafarian; Ali Farhoodi; Mahnoush Momeni; Mohammad Reza Babaei; Nooshafarin Kazemikhoo
Journal:  J Lasers Med Sci       Date:  2018-03-20

Review 2.  The Emerging Role of Non-Coding RNAs in Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Xiaoying Chen; Wei Xie; Ming Zhang; Yuhan Shi; Shaofen Xu; Haoyu Cheng; Lihong Wu; Janak L Pathak; Zhichao Zheng
Journal:  Front Cell Dev Biol       Date:  2022-05-16

Review 3.  Modifying MSC Phenotype to Facilitate Bone Healing: Biological Approaches.

Authors:  Stuart B Goodman; Tzuhua Lin
Journal:  Front Bioeng Biotechnol       Date:  2020-06-24

4.  Prevention of glucocorticoid-associated osteonecrosis by intravenous administration of mesenchymal stem cells in a rabbit model.

Authors:  Shusuke Ueda; Miyako Shimasaki; Toru Ichiseki; Yoshimichi Ueda; Masanobu Tsuchiya; Ayumi Kaneuji; Norio Kawahara
Journal:  BMC Musculoskelet Disord       Date:  2017-11-21       Impact factor: 2.362

Review 5.  Multiscale Stem Cell Technologies for Osteonecrosis of the Femoral Head.

Authors:  Yi Wang; Xibo Ma; Wei Chai; Jie Tian
Journal:  Stem Cells Int       Date:  2019-01-08       Impact factor: 5.443

6.  Can Hypoxic Conditioning Improve Bone Metabolism? A Systematic Review.

Authors:  Marta Camacho-Cardenosa; Alba Camacho-Cardenosa; Rafael Timón; Guillermo Olcina; Pablo Tomas-Carus; Javier Brazo-Sayavera
Journal:  Int J Environ Res Public Health       Date:  2019-05-21       Impact factor: 3.390

Review 7.  Efficacy and safety of stem cell therapy for the early-stage osteonecrosis of femoral head: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Lianghao Mao; Pan Jiang; Xuan Lei; Chenlie Ni; Yiming Zhang; Bing Zhang; Qiping Zheng; Dapeng Li
Journal:  Stem Cell Res Ther       Date:  2020-10-19       Impact factor: 6.832

Review 8.  Stem cell therapy for treating osteonecrosis of the femoral head: From clinical applications to related basic research.

Authors:  Rui Li; Qiu-Xia Lin; Xue-Zhen Liang; Guang-Bo Liu; He Tang; Yu Wang; Shi-Bi Lu; Jiang Peng
Journal:  Stem Cell Res Ther       Date:  2018-10-25       Impact factor: 6.832

Review 9.  Mesenchymal stromal cells for osteonecrosis.

Authors:  S Elgaz; H Bonig; P Bader
Journal:  J Transl Med       Date:  2020-10-20       Impact factor: 5.531

Review 10.  Efficacy and Safety of Stem Cell Combination Therapy for Osteonecrosis of the Femoral Head: A Systematic Review and Meta-Analysis.

Authors:  Junqiao Li; Peng Su; Jian Li; Gang Chen; Yan Xiong
Journal:  J Healthc Eng       Date:  2021-09-24       Impact factor: 2.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.